NO140057C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive alfa-aryl-4-substituerte piperidinoalkanol-derivater - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive alfa-aryl-4-substituerte piperidinoalkanol-derivaterInfo
- Publication number
- NO140057C NO140057C NO326/73A NO32673A NO140057C NO 140057 C NO140057 C NO 140057C NO 326/73 A NO326/73 A NO 326/73A NO 32673 A NO32673 A NO 32673A NO 140057 C NO140057 C NO 140057C
- Authority
- NO
- Norway
- Prior art keywords
- piperidinoal
- canol
- aryl
- derivatives
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22182172A | 1972-01-28 | 1972-01-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO140057B NO140057B (no) | 1979-03-19 |
| NO140057C true NO140057C (no) | 1979-07-04 |
Family
ID=22829539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO326/73A NO140057C (no) | 1972-01-28 | 1973-01-26 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive alfa-aryl-4-substituerte piperidinoalkanol-derivater |
Country Status (26)
| Country | Link |
|---|---|
| JP (1) | JPS5115035B2 (xx) |
| AR (1) | AR195314A1 (xx) |
| AT (2) | AT321917B (xx) |
| AU (1) | AU467361B2 (xx) |
| BE (1) | BE794597A (xx) |
| CA (1) | CA978946A (xx) |
| CH (2) | CH593259A5 (xx) |
| CS (1) | CS177834B2 (xx) |
| DD (1) | DD103239A5 (xx) |
| DE (1) | DE2303306C3 (xx) |
| DK (1) | DK136713B (xx) |
| ES (1) | ES410731A1 (xx) |
| FR (1) | FR2181690B1 (xx) |
| GB (1) | GB1413138A (xx) |
| HU (1) | HU166477B (xx) |
| IE (1) | IE36983B1 (xx) |
| IL (1) | IL41060A (xx) |
| LU (1) | LU66916A1 (xx) |
| NL (1) | NL175410C (xx) |
| NO (1) | NO140057C (xx) |
| PH (1) | PH10264A (xx) |
| PL (1) | PL89095B1 (xx) |
| SE (1) | SE382058B (xx) |
| SU (1) | SU464997A3 (xx) |
| YU (1) | YU36013B (xx) |
| ZA (1) | ZA728544B (xx) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3941795A (en) | 1974-02-08 | 1976-03-02 | Richardson-Merrell Inc. | α-ARYL-4-SUBSTITUTED PIPERIDINOALKANOL DERIVATIVES |
| US4254130A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
| US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
| IT1200123B (it) * | 1985-09-27 | 1989-01-05 | Ind Chimica Srl | Procedimento per la preparazione di alfa-(p-terbutilfenil)-4-(idrossidifenilmetil)-1-piperidinobutanolo |
| US4742175A (en) * | 1986-05-07 | 1988-05-03 | Merrell Dow Pharmaceuticals Inc. | Preparation of polymorphically pure terfenadine |
| JPS63101760U (xx) * | 1986-12-19 | 1988-07-02 | ||
| IT1205685B (it) * | 1987-05-26 | 1989-03-31 | Erregierre Spa | Processo per la preparazione di alfa-(alchilfenil)-4-(idrossi difenilmetil)-1-piperidina butanolo |
| IL93499A0 (en) * | 1989-02-28 | 1990-11-29 | Merrell Dow Pharma | Preparation of the low melting polymorphic form of terfenadine |
| ZA903145B (en) * | 1989-05-01 | 1991-02-27 | Merrell Dow Pharma | Process for the preparation of the high melting polymorphic form of terfenadine |
| DE3917241A1 (de) * | 1989-05-26 | 1990-11-29 | Schaper & Bruemmer Gmbh | 4-(hydroxydiphenylmethyl)-1-piperidyl-phenylalkan-derivate |
| EP0596120A4 (en) * | 1991-08-09 | 1994-07-06 | Yoshitomi Pharmaceutical | Thiophene compound. |
| AU705427B2 (en) * | 1995-05-08 | 1999-05-20 | Aventisub Ii Inc. | Alpha-(substituted alkylphenyl) -4-(hydroxydiphenylmethyl)-1-piperidine butanol derivatives, their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators |
| ATE260983T1 (de) * | 1997-03-11 | 2004-03-15 | Aventis Pharma Inc | Verfahren zur herstellung von 4-(4-(4- (hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl - alpha,alpha-dimenthylphenylessigsäure und phosphorylierter derivate |
| US7498345B2 (en) * | 2004-09-17 | 2009-03-03 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
| JPWO2006043691A1 (ja) | 2004-10-18 | 2008-05-29 | 株式会社リバース・プロテオミクス研究所 | 創薬標的タンパク質及び標的遺伝子、並びにスクリーニング方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3081303A (en) * | 1961-10-13 | 1963-03-12 | Searle & Co | 1-aminoalkyl-alpha, alpha-diphenylpiperidine-methanols |
| GB1242169A (en) * | 1969-04-09 | 1971-08-11 | Ucb Sa | Piperidine derivatives |
-
1972
- 1972-12-04 ZA ZA728544A patent/ZA728544B/xx unknown
- 1972-12-05 IE IE1689/72A patent/IE36983B1/xx unknown
- 1972-12-08 PH PH14156A patent/PH10264A/en unknown
- 1972-12-11 AU AU49893/72A patent/AU467361B2/en not_active Ceased
- 1972-12-12 IL IL41060A patent/IL41060A/xx unknown
- 1972-12-15 GB GB5799572A patent/GB1413138A/en not_active Expired
- 1972-12-20 CH CH1381476A patent/CH593259A5/xx not_active IP Right Cessation
- 1972-12-20 CH CH1854272A patent/CH587820A5/xx not_active IP Right Cessation
- 1972-12-27 JP JP47130136A patent/JPS5115035B2/ja not_active Expired
- 1972-12-29 AT AT1115372A patent/AT321917B/de not_active IP Right Cessation
- 1972-12-29 AT AT246074*1A patent/AT323742B/de not_active IP Right Cessation
-
1973
- 1973-01-08 YU YU34/73A patent/YU36013B/xx unknown
- 1973-01-16 CA CA161,413A patent/CA978946A/en not_active Expired
- 1973-01-17 HU HURI498A patent/HU166477B/hu unknown
- 1973-01-18 ES ES410731A patent/ES410731A1/es not_active Expired
- 1973-01-22 NL NLAANVRAGE7300873,A patent/NL175410C/xx not_active IP Right Cessation
- 1973-01-24 SE SE7300974A patent/SE382058B/xx active Protection Beyond IP Right Term
- 1973-01-24 FR FR7302503A patent/FR2181690B1/fr not_active Expired
- 1973-01-24 DE DE2303306A patent/DE2303306C3/de not_active Expired
- 1973-01-25 DD DD168482A patent/DD103239A5/xx unknown
- 1973-01-26 AR AR246313A patent/AR195314A1/es active
- 1973-01-26 LU LU66916A patent/LU66916A1/xx unknown
- 1973-01-26 BE BE794597D patent/BE794597A/xx not_active IP Right Cessation
- 1973-01-26 NO NO326/73A patent/NO140057C/no unknown
- 1973-01-26 DK DK44973AA patent/DK136713B/da not_active IP Right Cessation
- 1973-01-26 PL PL1973160419A patent/PL89095B1/pl unknown
- 1973-01-26 CS CS630A patent/CS177834B2/cs unknown
- 1973-01-27 SU SU1878074A patent/SU464997A3/ru active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO140059C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinderivater | |
| NO793013L (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater | |
| NO139560C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater | |
| NO137941C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt tri-p-toluensulfonat av s-adenosyl-l-methionin | |
| NO140381C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner | |
| NO138565C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater | |
| NO140058C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater | |
| NO136094C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive d-1-(4-amino-fenyl)-2-alkylamino-etanol-derivater. | |
| NO149281C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 7alfa-metoksycephalosporinderivater | |
| NO140057C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive alfa-aryl-4-substituerte piperidinoalkanol-derivater | |
| NO138999C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner | |
| NO140597C (no) | Analogifremgangsmaate ved fremstillingen av terapeutisk aktive 8-azapurin-6-on-derivater | |
| NO140670C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater | |
| NO140821C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater | |
| NO137858C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner | |
| NO142260C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater | |
| NO138063C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater | |
| NO137728C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater | |
| NO143499C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indanderivater | |
| NO140299C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner | |
| NO138251C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer | |
| NO139050C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater | |
| NO138285C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive lincomycinderivater | |
| NO137695C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser | |
| NO140007C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive indolcarboxylsyrer |